Therapy Areas: Diabetes
Aerpio Pharmaceuticals Completes Patient Dosing in TIME-2b Study of AKB-9778 in Diabetic Retinopathy
18 January 2019 - - US-based biopharmaceutical company Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) has completed patient dosing in the company's TIME-2b study, a Phase 2b clinical trial designed ...
vTv Therapeutics Publishes Comprehensive Data in Science Translational Medicine Detailing the Discovery and Clinical Development of TTP399, including Results of Phase 2 AGATA Study
18 January 2019 - - A new paper in Science Translational Medicine showcases the discovery and development of TTP399, an investigational, oral, small molecule, liver-selective glucokinase act...
Amedex to commence Phase 2 cDFU clinical trial of Nu-3 antimicrobial in patients with chronic diabetic foot ulcers in The Bahamas
18 January 2019 - Pharmaceuticals company Amedex Inc said on Thursday that it plans to conduct two Phase 2 cDFU clinical trial for its topically applied Nu-3 antimicrobial used to eliminate infection ...
Dance Biopharm Names Development, Finance Chiefs
17 January 2019 - - US-based clinical stage biopharma company Dance Biopharm Holdings Inc. has appointed Dr. Melissa Rhodes to the position of chief development officer and Michael Kaseta to the role ...
PharmaCyte Biotech Partner Encapsulates Live Cells for Clinical Trial in Pancreatic Cancer
17 January 2019 - - US-based biotechnology company PharmaCyte Biotech, Inc. (OTCQB: PMCB) partner Austrianova has successfully encapsulated the live cells used in PharmaCyte's therapy for it...
AgeX Therapeutics Publishes Data in Peer-Reviewed Journal to Advance Potential Cell Therapy AgeX-BAT1 for Type II Diabetes and Obesity
10 January 2019 - - US-based drug developer AgeX Therapeutics, Inc. (NYSE American: AGE) has published data relating to its cell therapy product candidate AgeX-BAT1 for Type II diabetes and obesity in...